aluates Reports

$ 0.0

Automative

Global Flow Cytometry in Oncology and Immunology Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-32E14374

Global Flow Cytometry in Oncology and Immunology Market Research Report 2023

BUY CHAPTERS

Global Flow Cytometry in Oncology and Immunology Market Research Report 2025

Code: QYRE-Auto-32E14374

Report

April 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent

Bio Rad Laboratories

Cell Signaling Technology

Cytek Biosciences

Danaher Corporation

Laboratory Corporation of America Holdings

Merck KGaA

Miltenyi Biotec

Neogenomics Laboratories

OPKO Health

Sony Group Corporation

Thermo Fisher Scientific Inc

ABYNTEK BIOPHARMA

DiaSorin S.p.A (Luminex Corporation),

Enzi Biochem Inc

Flow Cytometry in Oncology and Immunology Market

The global market for Flow Cytometry in Oncology and Immunology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Flow cytometry is a powerful technology that is widely used in both oncology and immunology research. It is a technique used to analyze the physical and chemical properties of cells in a heterogeneous population, by labeling and detecting specific molecules on the surface of cells. The resulting data can provide information about the number, size, and complexity of cells in a sample, as well as their phenotype and function.

In oncology, flow cytometry is often used to analyze cancer cells and to monitor the progression of the disease. For example, flow cytometry can be used to identify and quantify cancer stem cells, which are thought to be responsible for tumor initiation and recurrence. It can also be used to measure the expression of tumor-associated antigens, which are molecules expressed by cancer cells that can be targeted by immunotherapy.

Overall, flow cytometry is a versatile tool that has many applications in oncology and immunology research. It can provide valuable information about the biology of cells and their interactions with other cells and molecules, and can help researchers to develop new diagnostic and therapeutic approaches for cancer and other diseases

The global increase in HIV diagnoses is a significant market factor for flow cytometry, and this is because the flow cytometry technique is specifically used for HIV diagnosis. In flow cytometry, light scattering is utilized to identify cells. These cells receive particular markers known as CDs depending on the type of scattering (clusters of differentiation). The main market players are concentrating on creating new products, which is anticipated to propel market growth over the forecast year.

This report aims to provide a comprehensive presentation of the global market for Flow Cytometry in Oncology and Immunology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry in Oncology and Immunology.

The Flow Cytometry in Oncology and Immunology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flow Cytometry in Oncology and Immunology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Flow Cytometry in Oncology and Immunology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Flow Cytometry in Oncology and Immunology Market Report

Report Metric	Details
Report Name	Flow Cytometry in Oncology and Immunology Market
Segment by Type	Products Services
Segment by Application	Immunology Oncology Solid Tumor
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent, ABYNTEK BIOPHARMA, Bio-Rad Laboratories, Cell Signaling Technology, Cytek Biosciences, Danaher Corporation,, DiaSorin S.p.A (Luminex Corporation),, Enzi Biochem Inc, Laboratory Corporation of America Holdings,, Merck KGaA, Miltenyi Biotec, NeoGenomics Laboratories, OPKO Health, Sony Group Corporation, Thermo Fisher Scientific Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flow Cytometry in Oncology and Immunology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Flow Cytometry in Oncology and Immunology Market report?

Ans: The main players in the Flow Cytometry in Oncology and Immunology Market are Agilent, ABYNTEK BIOPHARMA, Bio-Rad Laboratories, Cell Signaling Technology, Cytek Biosciences, Danaher Corporation,, DiaSorin S.p.A (Luminex Corporation),, Enzi Biochem Inc, Laboratory Corporation of America Holdings,, Merck KGaA, Miltenyi Biotec, NeoGenomics Laboratories, OPKO Health, Sony Group Corporation, Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Flow Cytometry in Oncology and Immunology Market report?

Ans: The Applications covered in the Flow Cytometry in Oncology and Immunology Market report are Immunology, Oncology, Solid Tumor

What are the Type segmentation covered in the Flow Cytometry in Oncology and Immunology Market report?

Ans: The Types covered in the Flow Cytometry in Oncology and Immunology Market report are Products, Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Products

1.2.3 Services

1.3 Market by Application

1.3.1 Global Flow Cytometry in Oncology and Immunology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Immunology

1.3.3 Oncology

1.3.4 Solid Tumor

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Flow Cytometry in Oncology and Immunology Market Perspective (2020-2031)

2.2 Global Flow Cytometry in Oncology and Immunology Growth Trends by Region

2.2.1 Global Flow Cytometry in Oncology and Immunology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Flow Cytometry in Oncology and Immunology Historic Market Size by Region (2020-2025)

2.2.3 Flow Cytometry in Oncology and Immunology Forecasted Market Size by Region (2026-2031)

2.3 Flow Cytometry in Oncology and Immunology Market Dynamics

2.3.1 Flow Cytometry in Oncology and Immunology Industry Trends

2.3.2 Flow Cytometry in Oncology and Immunology Market Drivers

2.3.3 Flow Cytometry in Oncology and Immunology Market Challenges

2.3.4 Flow Cytometry in Oncology and Immunology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue

3.1.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue (2020-2025)

3.1.2 Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Players (2020-2025)

3.2 Global Flow Cytometry in Oncology and Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Flow Cytometry in Oncology and Immunology Revenue

3.4 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio

3.4.1 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology and Immunology Revenue in 2024

3.5 Global Key Players of Flow Cytometry in Oncology and Immunology Head office and Area Served

3.6 Global Key Players of Flow Cytometry in Oncology and Immunology, Product and Application

3.7 Global Key Players of Flow Cytometry in Oncology and Immunology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Flow Cytometry in Oncology and Immunology Breakdown Data by Type

4.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Type (2020-2025)

4.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Type (2026-2031)

5 Flow Cytometry in Oncology and Immunology Breakdown Data by Application

5.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Application (2020-2025)

5.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Flow Cytometry in Oncology and Immunology Market Size (2020-2031)

6.2 North America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)

6.4 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Flow Cytometry in Oncology and Immunology Market Size (2020-2031)

7.2 Europe Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)

7.4 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size (2020-2031)

8.2 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2020-2025)

8.4 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Flow Cytometry in Oncology and Immunology Market Size (2020-2031)

9.2 Latin America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)

9.4 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size (2020-2031)

10.2 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)

10.4 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent

11.1.1 Agilent Company Details

11.1.2 Agilent Business Overview

11.1.3 Agilent Flow Cytometry in Oncology and Immunology Introduction

11.1.4 Agilent Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.1.5 Agilent Recent Development

11.2 ABYNTEK BIOPHARMA

11.2.1 ABYNTEK BIOPHARMA Company Details

11.2.2 ABYNTEK BIOPHARMA Business Overview

11.2.3 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Introduction

11.2.4 ABYNTEK BIOPHARMA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.2.5 ABYNTEK BIOPHARMA Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Details

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Introduction

11.3.4 Bio-Rad Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Cell Signaling Technology

11.4.1 Cell Signaling Technology Company Details

11.4.2 Cell Signaling Technology Business Overview

11.4.3 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Introduction

11.4.4 Cell Signaling Technology Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.4.5 Cell Signaling Technology Recent Development

11.5 Cytek Biosciences

11.5.1 Cytek Biosciences Company Details

11.5.2 Cytek Biosciences Business Overview

11.5.3 Cytek Biosciences Flow Cytometry in Oncology and Immunology Introduction

11.5.4 Cytek Biosciences Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.5.5 Cytek Biosciences Recent Development

11.6 Danaher Corporation,

11.6.1 Danaher Corporation, Company Details

11.6.2 Danaher Corporation, Business Overview

11.6.3 Danaher Corporation, Flow Cytometry in Oncology and Immunology Introduction

11.6.4 Danaher Corporation, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.6.5 Danaher Corporation, Recent Development

11.7 DiaSorin S.p.A (Luminex Corporation),

11.7.1 DiaSorin S.p.A (Luminex Corporation), Company Details

11.7.2 DiaSorin S.p.A (Luminex Corporation), Business Overview

11.7.3 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Introduction

11.7.4 DiaSorin S.p.A (Luminex Corporation), Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.7.5 DiaSorin S.p.A (Luminex Corporation), Recent Development

11.8 Enzi Biochem Inc

11.8.1 Enzi Biochem Inc Company Details

11.8.2 Enzi Biochem Inc Business Overview

11.8.3 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Introduction

11.8.4 Enzi Biochem Inc Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.8.5 Enzi Biochem Inc Recent Development

11.9 Laboratory Corporation of America Holdings,

11.9.1 Laboratory Corporation of America Holdings, Company Details

11.9.2 Laboratory Corporation of America Holdings, Business Overview

11.9.3 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Introduction

11.9.4 Laboratory Corporation of America Holdings, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.9.5 Laboratory Corporation of America Holdings, Recent Development

11.10 Merck KGaA

11.10.1 Merck KGaA Company Details

11.10.2 Merck KGaA Business Overview

11.10.3 Merck KGaA Flow Cytometry in Oncology and Immunology Introduction

11.10.4 Merck KGaA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.10.5 Merck KGaA Recent Development

11.11 Miltenyi Biotec

11.11.1 Miltenyi Biotec Company Details

11.11.2 Miltenyi Biotec Business Overview

11.11.3 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Introduction

11.11.4 Miltenyi Biotec Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.11.5 Miltenyi Biotec Recent Development

11.12 NeoGenomics Laboratories

11.12.1 NeoGenomics Laboratories Company Details

11.12.2 NeoGenomics Laboratories Business Overview

11.12.3 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Introduction

11.12.4 NeoGenomics Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.12.5 NeoGenomics Laboratories Recent Development

11.13 OPKO Health

11.13.1 OPKO Health Company Details

11.13.2 OPKO Health Business Overview

11.13.3 OPKO Health Flow Cytometry in Oncology and Immunology Introduction

11.13.4 OPKO Health Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.13.5 OPKO Health Recent Development

11.14 Sony Group Corporation

11.14.1 Sony Group Corporation Company Details

11.14.2 Sony Group Corporation Business Overview

11.14.3 Sony Group Corporation Flow Cytometry in Oncology and Immunology Introduction

11.14.4 Sony Group Corporation Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.14.5 Sony Group Corporation Recent Development

11.15 Thermo Fisher Scientific Inc.

11.15.1 Thermo Fisher Scientific Inc. Company Details

11.15.2 Thermo Fisher Scientific Inc. Business Overview

11.15.3 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Introduction

11.15.4 Thermo Fisher Scientific Inc. Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)

11.15.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agilent

Bio Rad Laboratories

Cell Signaling Technology

Cytek Biosciences

Danaher Corporation

Laboratory Corporation of America Holdings

Merck KGaA

Miltenyi Biotec

Neogenomics Laboratories

OPKO Health

Sony Group Corporation

Thermo Fisher Scientific Inc

ABYNTEK BIOPHARMA

DiaSorin S.p.A (Luminex Corporation),

Enzi Biochem Inc

List of Tables

Table 1. Global Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Products

Table 3. Key Players of Services

Table 4. Global Flow Cytometry in Oncology and Immunology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Flow Cytometry in Oncology and Immunology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Flow Cytometry in Oncology and Immunology Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Flow Cytometry in Oncology and Immunology Market Share by Region (2020-2025)

Table 8. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Flow Cytometry in Oncology and Immunology Market Share by Region (2026-2031)

Table 10. Flow Cytometry in Oncology and Immunology Market Trends

Table 11. Flow Cytometry in Oncology and Immunology Market Drivers

Table 12. Flow Cytometry in Oncology and Immunology Market Challenges

Table 13. Flow Cytometry in Oncology and Immunology Market Restraints

Table 14. Global Flow Cytometry in Oncology and Immunology Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Flow Cytometry in Oncology and Immunology Market Share by Players (2020-2025)

Table 16. Global Top Flow Cytometry in Oncology and Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology and Immunology as of 2024)

Table 17. Ranking of Global Top Flow Cytometry in Oncology and Immunology Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Flow Cytometry in Oncology and Immunology Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Flow Cytometry in Oncology and Immunology, Headquarters and Area Served

Table 20. Global Key Players of Flow Cytometry in Oncology and Immunology, Product and Application

Table 21. Global Key Players of Flow Cytometry in Oncology and Immunology, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Flow Cytometry in Oncology and Immunology Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Type (2020-2025)

Table 25. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Type (2026-2031)

Table 27. Global Flow Cytometry in Oncology and Immunology Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Application (2020-2025)

Table 29. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Application (2026-2031)

Table 31. North America Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)

Table 46. Agilent Company Details

Table 47. Agilent Business Overview

Table 48. Agilent Flow Cytometry in Oncology and Immunology Product

Table 49. Agilent Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 50. Agilent Recent Development

Table 51. ABYNTEK BIOPHARMA Company Details

Table 52. ABYNTEK BIOPHARMA Business Overview

Table 53. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product

Table 54. ABYNTEK BIOPHARMA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 55. ABYNTEK BIOPHARMA Recent Development

Table 56. Bio-Rad Laboratories Company Details

Table 57. Bio-Rad Laboratories Business Overview

Table 58. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product

Table 59. Bio-Rad Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 60. Bio-Rad Laboratories Recent Development

Table 61. Cell Signaling Technology Company Details

Table 62. Cell Signaling Technology Business Overview

Table 63. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product

Table 64. Cell Signaling Technology Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 65. Cell Signaling Technology Recent Development

Table 66. Cytek Biosciences Company Details

Table 67. Cytek Biosciences Business Overview

Table 68. Cytek Biosciences Flow Cytometry in Oncology and Immunology Product

Table 69. Cytek Biosciences Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 70. Cytek Biosciences Recent Development

Table 71. Danaher Corporation, Company Details

Table 72. Danaher Corporation, Business Overview

Table 73. Danaher Corporation, Flow Cytometry in Oncology and Immunology Product

Table 74. Danaher Corporation, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 75. Danaher Corporation, Recent Development

Table 76. DiaSorin S.p.A (Luminex Corporation), Company Details

Table 77. DiaSorin S.p.A (Luminex Corporation), Business Overview

Table 78. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product

Table 79. DiaSorin S.p.A (Luminex Corporation), Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 80. DiaSorin S.p.A (Luminex Corporation), Recent Development

Table 81. Enzi Biochem Inc Company Details

Table 82. Enzi Biochem Inc Business Overview

Table 83. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product

Table 84. Enzi Biochem Inc Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 85. Enzi Biochem Inc Recent Development

Table 86. Laboratory Corporation of America Holdings, Company Details

Table 87. Laboratory Corporation of America Holdings, Business Overview

Table 88. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product

Table 89. Laboratory Corporation of America Holdings, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 90. Laboratory Corporation of America Holdings, Recent Development

Table 91. Merck KGaA Company Details

Table 92. Merck KGaA Business Overview

Table 93. Merck KGaA Flow Cytometry in Oncology and Immunology Product

Table 94. Merck KGaA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 95. Merck KGaA Recent Development

Table 96. Miltenyi Biotec Company Details

Table 97. Miltenyi Biotec Business Overview

Table 98. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product

Table 99. Miltenyi Biotec Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 100. Miltenyi Biotec Recent Development

Table 101. NeoGenomics Laboratories Company Details

Table 102. NeoGenomics Laboratories Business Overview

Table 103. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product

Table 104. NeoGenomics Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 105. NeoGenomics Laboratories Recent Development

Table 106. OPKO Health Company Details

Table 107. OPKO Health Business Overview

Table 108. OPKO Health Flow Cytometry in Oncology and Immunology Product

Table 109. OPKO Health Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 110. OPKO Health Recent Development

Table 111. Sony Group Corporation Company Details

Table 112. Sony Group Corporation Business Overview

Table 113. Sony Group Corporation Flow Cytometry in Oncology and Immunology Product

Table 114. Sony Group Corporation Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 115. Sony Group Corporation Recent Development

Table 116. Thermo Fisher Scientific Inc. Company Details

Table 117. Thermo Fisher Scientific Inc. Business Overview

Table 118. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product

Table 119. Thermo Fisher Scientific Inc. Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)

Table 120. Thermo Fisher Scientific Inc. Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Flow Cytometry in Oncology and Immunology Picture

Figure 2. Global Flow Cytometry in Oncology and Immunology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Flow Cytometry in Oncology and Immunology Market Share by Type: 2024 VS 2031

Figure 4. Products Features

Figure 5. Services Features

Figure 6. Global Flow Cytometry in Oncology and Immunology Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Flow Cytometry in Oncology and Immunology Market Share by Application: 2024 VS 2031

Figure 8. Immunology Case Studies

Figure 9. Oncology Case Studies

Figure 10. Solid Tumor Case Studies

Figure 11. Flow Cytometry in Oncology and Immunology Report Years Considered

Figure 12. Global Flow Cytometry in Oncology and Immunology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Flow Cytometry in Oncology and Immunology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Flow Cytometry in Oncology and Immunology Market Share by Region: 2024 VS 2031

Figure 15. Global Flow Cytometry in Oncology and Immunology Market Share by Players in 2024

Figure 16. Global Top Flow Cytometry in Oncology and Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology and Immunology as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology and Immunology Revenue in 2024

Figure 18. North America Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)

Figure 20. United States Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)

Figure 24. Germany Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Share by Region (2020-2031)

Figure 32. China Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)

Figure 40. Mexico Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)

Figure 44. Turkey Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Agilent Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 48. ABYNTEK BIOPHARMA Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 50. Cell Signaling Technology Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 51. Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 52. Danaher Corporation, Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 53. DiaSorin S.p.A (Luminex Corporation), Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 54. Enzi Biochem Inc Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 55. Laboratory Corporation of America Holdings, Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 56. Merck KGaA Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 57. Miltenyi Biotec Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 58. NeoGenomics Laboratories Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 59. OPKO Health Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 60. Sony Group Corporation Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 61. Thermo Fisher Scientific Inc. Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Flow Cytometry in Oncology Market Research Report 2024

Infrared Flow Cytometry Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Flow Detection Service Market Research Report 2024

Research Flow Cytometry Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Flow Cytometric Market Research Report 2024

Global Flow Cytometry Solutions Market Research Report 2025

Global Flow Cytometry Service Market Research Report 2024

Global Fluorescence Activated Cell Sorting Market Research Report 2024

Flow Cytometry System Market

Laser Flow Cytometers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Flow Cytometer Market Research Report 2025

Flow Cytometry Testing Technology Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Flow Cytometry Product Market Research Report 2024

Global Analytical Flow Cytometry Market Research Report 2024

Automatic Flow Cytometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Desktop Cytometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ultra high speed Sorting Flow Cytometer Market Research Report 2024

Benchtop Flow Cytometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global High Speed Flow Cytometry Sorter Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions